Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yujie Huang"'
Autor:
Yujie Huang, You Zhai, Meijia Wu, Chengdong Chang, Jindan Luo, Dongsheng Hong, Qingwei Zhao, Yao Dai, Jian Liu
Publikováno v:
Drug Design, Development and Therapy. 16:3817-3828
Yujie Huang,1 You Zhai,1 Meijia Wu,1 Chengdong Chang,2 Jindan Luo,3 Dongsheng Hong,1 Qingwei Zhao,1 Yao Dai,4 Jian Liu1 1Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Af
Autor:
Fengxian Qin, Fan Yang, Xuexiang Liu, Song Shi, Yujie Huang, Jifei Chen, Wen-wu Liang, Lin Miao, Xiao-mou Wei
Publikováno v:
Mediators of Inflammation
Mediators of Inflammation, Vol 2021 (2021)
Mediators of Inflammation, Vol 2021 (2021)
Background. The functional characteristics of NLRP3 in the pathogenesis of coxsackievirus B3- (CVB3-) induced viral myocarditis (VMC) have not been fully elucidated, and the targeted therapeutic effect of NLRP3 or its related pathway in VMC has not b
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-10 (2020)
Nature Communications
Nature Communications
Metastasis can occur following surgical resection of solid tumors and metastasis is the main cause of cancer death. The role of anesthetics used during surgery in cancer metastasis and the underlying mechanism remains largely unknown. Here we show th
Autor:
Fangfang Cheng, Yi Luo, Qiang Fu, Huanru Fu, Yujie Huang, Longxin Qiu, Kailong Zhang, Chao Xing
Publikováno v:
Journal of materials chemistry. B. 9(40)
For the purpose of efficient targeted therapies, suppressing phagocytosis by a mononuclear phagocyte system (MPS), enhancing the "active" targeted delivery, and meeting clinical production criteria are extremely critical for engineering strategies of
Autor:
Mingzhu Huang, Yong Ren, Yujie Huang, Xiaozhuan Li, Xingguang Liang, Feng Han, Xin Li, Juan Cheng
Publikováno v:
Analytical chemistry. 92(1)
Interrogating metabolite crosstalk in live cells is important to understand the interplay between metabolic and signal transduction pathways but is challenging due to the lack of efficient analytical techniques. Here we report a sequentially activate
Publikováno v:
Oncology Research
Although increasing evidence indicates that the deregulation of microRNAs (miRNAs) contributes to tumorigenesis and invasion, little is known about the role of miR-133b in human non-small cell lung cancer (NSCLC). In the present study, we revealed th
Autor:
Jane Zhang, Rachel Yanowitch, Yujie Huang, William S. Cobb, Jeffrey P. Greenfield, Prajwal Rajappa, Babacar Cisse, David J. Pisapia, Beiyi Shen, Jason T. Huse, Jacqueline Bromberg, David Lyden, Caitlin Hoffman, Kunal Garg, Timothy A. Chan, Sara Haddock, Laura Daly, Emma Vartanian
Publikováno v:
Clinical Cancer Research. 23:3109-3119
Purpose: While the tumor microenvironment has been known to play an integral role in tumor progression, the function of nonresident bone marrow–derived cells (BMDC) remains to be determined in neurologic tumors. Here we identified the contribution
Autor:
Xingwu Jiang, Ofer Reizes, Weiqiang Lu, Ruth Nussinov, Charis Eng, Qi Wang, Yuan Hou, Yujie Huang, Justin D. Lathia, Zihao Wang, Feixiong Cheng, Jiansong Fang
Publikováno v:
Cell Chem Biol
Summary Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease that lacks clinically actionable genetic alterations that limit targeted therapies. Here we explore a systems pharmacology approach that integrates drug-target ne
Autor:
Jiafeng Wang, Yumiao Qiu, Jing Huang, Bin Wu, Hongli Gu, Yan Zhen, Chenglin Li, Zhengyi Luo, Zhe Hu, Yujie Huang
Publikováno v:
Molecular Medicine Reports.
4-aminopyridine (4-AP), a voltage-gated potassium channel blocker, was revealed to possess pro‑apoptotic properties in various types of cancer cells. The present study aimed to explore the effect of 4‑AP on a cisplatin (DDP) resistant lung cancer
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Background Breast cancer accounts for nearly a quarter of all cancers in women worldwide, and more than 90% of women diagnosed with breast cancer undergo mastectomy or breast-conserving surgery. Retrospective clinical studies have suggested that use